Literature DB >> 7851192

Interleukin-2 receptor alpha and beta chain expression by circulating alpha beta and gamma delta T cells in inflammatory bowel disease.

I Kirman1, O H Nielsen, E Kjaersgaard, J Brynskov.   

Abstract

The pathogenetic role of activated alpha beta and gamma delta T cells in inflammatory bowel disease (IBD) is not well defined. To elucidate this, interleukin-2 receptor (IL-2R) alpha and IL-2R beta single chain expression and coexpression by peripheral blood TCR alpha beta + cells and TCR gamma delta + cells was studied in 21 patients with ulcerative colitis (UC), 25 with Crohn's disease (CD), and 15 controls. The percentages of IL-2R alpha + beta-, IL-2R alpha-beta +, and IL-2R alpha + beta + TCR alpha beta + cells were increased in IBD patients with moderate and severe disease activity, as compared to controls (P < 0.01). In contrast, the percentages of IL-2R alpha-beta + and IL-2R alpha + beta + TCR gamma delta + cells were increased in patients with inactive UC (P < 0.01), but not in CD. The results suggest that activated alpha beta T cells are involved in the development of IBD. The differences in gamma delta T cell IL-2R expression between inactive UC and CD may correspond to a yet undefined etiopathogenetic difference between these two diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7851192     DOI: 10.1007/bf02065412

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.

Authors:  J E Crabtree; L D Juby; R V Heatley; A J Lobo; D W Bullimore; A T Axon
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 2.  The role of ciclosporin therapy in Crohn's disease. A review.

Authors:  J Brynskov
Journal:  Dig Dis       Date:  1991       Impact factor: 2.404

3.  Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

Authors:  F Pallone; S Fais; O Squarcia; L Biancone; P Pozzilli; M Boirivant
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

Review 4.  Alterations of the immune system in ulcerative colitis and Crohn's disease.

Authors:  R P MacDermott; W F Stenson
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

5.  Cloning of the gamma chain of the human IL-2 receptor.

Authors:  T Takeshita; H Asao; K Ohtani; N Ishii; S Kumaki; N Tanaka; H Munakata; M Nakamura; K Sugamura
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

6.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.

Authors:  M Noguchi; Y Nakamura; S M Russell; S F Ziegler; M Tsang; X Cao; W J Leonard
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

7.  Immune activation genes in inflammatory bowel disease.

Authors:  T Matsuura; G A West; K R Youngman; J S Klein; C Fiocchi
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

8.  Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.

Authors:  J Brynskov; N Tvede
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

9.  Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.

Authors:  J Brynskov; N Tvede; C B Andersen; M Vilien
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

10.  Soluble interleukin-2 receptors in ulcerative colitis.

Authors:  O H Nielsen; J Brynskov
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

View more
  6 in total

Review 1.  Microscopic enteritis: Bucharest consensus.

Authors:  Kamran Rostami; David Aldulaimi; Geoffrey Holmes; Matt W Johnson; Marie Robert; Amitabh Srivastava; Jean-François Fléjou; David S Sanders; Umberto Volta; Mohammad H Derakhshan; James J Going; Gabriel Becheanu; Carlo Catassi; Mihai Danciu; Luke Materacki; Kamran Ghafarzadegan; Sauid Ishaq; Mohammad Rostami-Nejad; A Salvador Peña; Gabrio Bassotti; Michael N Marsh; Vincenzo Villanacci
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

2.  Expression of common gamma chain on peripheral blood mononuclear cells in Crohn's disease.

Authors:  I Kirman; O H Nielsen
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

3.  Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation.

Authors:  J Meenan; J Spaans; T A Grool; S T Pals; G N Tytgat; S J van Deventer
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

4.  Bacterial superantigens and T cell receptor beta-chain-bearing T cells in the immunopathogenesis of ulcerative colitis.

Authors:  N Shiobara; Y Suzuki; H Aoki; A Gotoh; Y Fujii; Y Hamada; S Suzuki; N Fukui; I Kurane; T Itoh; R Suzuki
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

5.  Increased mucosal concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), sE-selectin, and interleukin-8 in active ulcerative colitis.

Authors:  O H Nielsen; J Brynskov; B Vainer
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

6.  Prostaglandin E₂ promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase.

Authors:  Chengcan Yao; Takako Hirata; Kitipong Soontrapa; Xiaojun Ma; Hiroshi Takemori; Shuh Narumiya
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.